Streetbeat News

VBLT

Vascular Biogenics Ltd

http://www.vblrx.com

CEO

Dror Harats

Employees

Industry

Pharmaceutical Preparation Manufacturing

vascular biogenics ltd. is a biotechnology company located in 6yonatan netanyahu street, yehud, center district, israel.

Open

0.17

Mkt cap

12M

Volume

5.4M

High

0.19

P/E Ratio

-0.87

52-wk high

0.32

Low

0.15

Div yield

N/A

52-wk low

0.10

Several stocks are experiencing significant pre-market movements. Immunic, Inc. (NASDAQ:IMUX) shares gained 13.2% after positive interim data from a Phase 2 trial. SuperCom Ltd. (NASDAQ:SPCB), Tempest Therapeutics, Inc. (NASDAQ:TPST), Mobilicom Limited (NASDAQ:MOB), SMX (Security Matters) Public Limited Company (NASDAQ:SMX), ContraFect Corporation (NASDAQ:CFRX), and ParaZero Technologies Ltd. (NASDAQ:PRZO) also saw pre-market gains. On the other hand, Borqs Technologies, Inc. (NASDAQ:BRQS), Phoenix Motor Inc. (NASDAQ:PEV), Atreca, Inc. (NASDAQ:BCEL), RVL Pharmaceuticals plc (NASDAQ:RVLP), Molekule Group, Inc. (NASDAQ:MKUL), Windtree Therapeutics, Inc. (NASDAQ:WINT), Applied UV, Inc. (NASDAQ:AUVI), Vascular Biogenics Ltd. (NASDAQ:VBLT), Maison Solutions Inc. (NASDAQ:MSS), and Future FinTech Group Inc. (NASDAQ:FTFT) experienced pre-market losses.

Portfolio Pulse from Lisa Levin

October 10, 2023 | 12:20 pm

Several stocks are moving in pre-market trading. Maris-Tech Ltd. (MTEK) shares rose 38% after the launch of Jupiter Drones. ParaZero Technologies Ltd. (PRZO) shares gained 27.6% after receiving authorization for drones to operate over populated areas. Avidity Biosciences, Inc. (RNA) rose 9.1% after disclosing positive AOC 1001 data. Shift Technologies, Inc. (SFT) fell 85% as it intends to file a voluntary Chapter 11 petition. Kubient, Inc. (KBNT) shares fell 21.2% after implementing a 36% reduction in the company's workforce.

Portfolio Pulse from Lisa Levin

October 09, 2023 | 12:20 pm

VBL Therapeutics (NASDAQ:VBLT) has announced that its S-4 registration statement for the proposed merger with Notable Labs has been declared effective by the SEC. The merger, announced on February 23, 2023, is expected to close in mid-October 2023, subject to shareholder approval. The combined organization plans to apply Notable's Predictive Precision Medicines Platform to develop a pipeline of clinical-stage precision medicines in oncology.

Portfolio Pulse from Happy Mohamed

September 06, 2023 | 12:02 pm

Vascular Biogenics (NASDAQ:VBLT) reported Q2 losses of $(0.01) per share, a 91.67% increase over losses of $(0.12) per share from the same period last year.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:24 pm

Vascular Biogenics (NASDAQ:VBLT) is set to release its latest quarterly earnings report on Friday, 2023-05-26, with analysts estimating an EPS of $-0.15. The company's historical earnings performance shows mixed results, and its stock is down 89.01% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

May 25, 2023 | 2:11 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.